Exagen (XGN) Other financing activities (2020 - 2025)

Exagen (XGN) posted Other financing activities of $199000.0 for Q3 2025, down 67.11% quarter-over-quarter from $605000.0 in Q2 2025.

Exagen (XGN) Other financing activities (2020 - 2025) Analysis & Trends

Exagen (XGN) has reported Other financing activities for 3 consecutive years, with $199000.0 the latest figure, recorded in Q3 2025.

Other financing activities for Q3 2025 came in at $199000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $804000.0 (up 1136.92% YoY), and the FY2025 annual result was $869000.0, changed N/A from the prior year.
Other financing activities was $199000.0 for Q3 2025 at Exagen, down from $605000.0 in the prior quarter.
Over five years, Other financing activities peaked at $4.2 million in Q1 2021 and troughed at $65000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Exagen	112.36 Mn	90.84 Mn	10.21 Mn

Download Data